scholarly journals Design and Prototyping of a Handheld 3-DOF Laparoscopic Ultrasound Manipulator for Liver Surgery

Procedia CIRP ◽  
2016 ◽  
Vol 49 ◽  
pp. 121-124 ◽  
Author(s):  
Hideyuki Sato ◽  
Kanako Harada ◽  
Jumpei Arata ◽  
Susumu Oguri ◽  
Shinya Onogi ◽  
...  
Keyword(s):  
Liver Surgery ◽  
Laparoscopic Ultrasound

Laparoscopic ultrasound navigation in liver surgery—technical aspects and feasibility

2004 ◽  
Vol 1268 ◽  
pp. 793-796 ◽  
Author(s):  
M Kleemann ◽  
P Hildebrand ◽  
R Keller ◽  
H.P Bruch ◽  
M Birth
Keyword(s):  
Liver Surgery ◽  
Laparoscopic Ultrasound ◽  
Technical Aspects

Intraoperative and Laparoscopic Ultrasound During Liver Surgery

2014 ◽  
pp. 201-218
Author(s):  
Gabriella Pittau ◽  
Michele Tedeschi ◽  
Denis Castaing
Keyword(s):  
Liver Surgery ◽  
Laparoscopic Ultrasound

Laparoscopic Ultrasound: Impact in Liver Surgery

2013 ◽  
pp. 217-229
Author(s):  
Alessandro Ferrero ◽  
Luca Viganò ◽  
Roberto Lo Tesoriere ◽  
Lorenzo Capussotti
Keyword(s):  
Liver Surgery ◽  
Laparoscopic Ultrasound

Laparoscopic ultrasound navigation in liver surgery: technical aspects and accuracy

2006 ◽  
Vol 20 (5) ◽  
pp. 726-729 ◽  
Author(s):  
M. Kleemann ◽  
P. Hildebrand ◽  
M. Birth ◽  
H. P. Bruch
Keyword(s):  
Liver Surgery ◽  
Laparoscopic Ultrasound ◽  
Technical Aspects

Liver Surgery for Breast Cancer Metastases

2009 ◽  
Vol 69 (05) ◽  
Author(s):  
EC Schest ◽  
H Cerwenka ◽  
A El-Shabrawi ◽  
H Bacher ◽  
HJ Mischinger
Keyword(s):  
Breast Cancer ◽  
Liver Surgery ◽  
Breast Cancer Metastases ◽  
Cancer Metastases

The changing scene of liver surgery

1990 ◽  
Vol 152 (10) ◽  
pp. 505-506 ◽  
Author(s):  
Kenneth J Hardy
Keyword(s):  
Liver Surgery

scholarly journals Biological impact of an enhanced recovery after surgery programme in liver surgery

BJS Open ◽  
2020 ◽  
Vol 5 (2) ◽  
Author(s):  
S Gonvers ◽  
J Jurt ◽  
G -R Joliat ◽  
N Halkic ◽  
E Melloul ◽  
...  
Keyword(s):  
Liver Surgery ◽  
Enhanced Recovery ◽  
Enhanced Recovery After Surgery ◽  
Surgical Stress ◽  
Multivariable Analysis ◽  
Albumin Concentration ◽  
Biological Impact ◽  
Reactive Protein ◽  
Before And After ◽  
Major Resection

Abstract Background The clinical and economic impacts of enhanced recovery after surgery (ERAS) programmes have been demonstrated extensively. Whether ERAS protocols also have a biological effect remains unclear. This study aimed to investigate the biological impact of an ERAS programme in patients undergoing liver surgery. Methods A retrospective analysis of patients undergoing liver surgery (2010–2018) was undertaken. Patients operated before and after ERAS implementation in 2013 were compared. Surrogate markers of surgical stress were monitored: white blood cell count (WBC), C-reactive protein (CRP) level, albumin concentration, and haematocrit. Their perioperative fluctuations were defined as Δvalues, calculated on postoperative day (POD) 0 for Δalbumin and Δhaematocrit and POD 2 for ΔWBC and ΔCRP. Results A total of 541 patients were included, with 223 and 318 patients in non-ERAS and ERAS groups respectively. Groups were comparable, except for higher rates of laparoscopy (24.8 versus 11.2 per cent; P < 0.001) and major resection (47.5 versus 38.1 per cent; P = 0.035) in the ERAS group. Patients in the ERAS group showed attenuated ΔWBC (2.00 versus 2.75 g/l; P = 0.013), ΔCRP (60 versus 101 mg/l; P <0.001) and Δalbumin (12 versus 16 g/l; P < 0.001) compared with those in the no-ERAS group. Subgroup analysis of open resection showed similar results. Multivariable analysis identified ERAS as the only independent factor associated with high ΔWBC (odds ratio (OR) 0.65, 95 per cent c.i. 0.43 to 0.98; P = 0.038), ΔCRP (OR 0.41, 0.23 to 0.73; P = 0.003) and Δalbumin (OR 0.40, 95 per cent c.i. 0.22 to 0.72; P = 0.002). Conclusion Compared with conventional management, implementation of ERAS was associated with an attenuated stress response in patients undergoing liver surgery.

The changing scene of liver surgery

1990 ◽  
Vol 153 (7) ◽  
pp. 433-433
Author(s):  
Kenneth J Hardy
Keyword(s):  
Liver Surgery

scholarly journals Robotic and laparoscopic liver surgery for colorectal liver metastases: an experience from a German Academic Center

2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Mirhasan Rahimli ◽  
Aristotelis Perrakis ◽  
Vera Schellerer ◽  
Andrew Gumbs ◽  
Eric Lorenz ◽  
...  
Keyword(s):  
Abdominal Surgery ◽  
Minimally Invasive ◽  
Liver Surgery ◽  
Colorectal Liver Metastases ◽  
Survival Rates ◽  
Long Term Outcomes ◽  
Short Term ◽  
Minimally Invasive Liver Surgery ◽  
Previous Abdominal Surgery

Abstract Background Minimally invasive liver surgery (MILS) in the treatment of colorectal liver metastases (CRLM) is increasing in incidence. The aim of this work was to present our experience by reporting short-term and long-term outcomes after MILS for CRLM with comparative analysis of laparoscopic (LLS) and robotic liver surgery (RLS). Methods Twenty-five patients with CRLM, who underwent MILS between May 2012 and March 2020, were selected from our retrospective registry of minimally invasive liver surgery (MD-MILS). Thirteen of these patients underwent LLS and 12 RLS. Short-term and long-term outcomes of both groups were analyzed. Results Operating time was significantly longer in the RLS vs. the LLS group (342.0 vs. 200.0 min; p = 0.004). There was no significant difference between the laparoscopic vs. the robotic group regarding length of postoperative stay (8.8 days), measured blood loss (430.4 ml), intraoperative blood transfusion, overall morbidity (20.0%), and liver surgery related morbidity (4%). The mean BMI was 27.3 (range from 19.2 to 44.8) kg/m2. The 30-day mortality was 0%. R0 resection was achieved in all patients (100.0%) in RLS vs. 10 patients (76.9%) in LLS. Major resections were carried out in 32.0% of the cases, and 84.0% of the patients showed intra-abdominal adhesions due to previous abdominal surgery. In 24.0% of cases, the tumor was bilobar, the maximum number of tumors removed was 9, and the largest tumor was 8.5 cm in diameter. The 1-, 3- and 5-year overall survival rates were 84, 56.9, and 48.7%, respectively. The 1- and 3-year overall recurrence-free survival rates were 49.6 and 36.2%, respectively, without significant differences between RLS vs. LLS. Conclusion Minimally invasive liver surgery for CRLM is safe and feasible. Minimally invasive resection of multiple lesions and large tumors is also possible. RLS may help to achieve higher rates of R0 resections. High BMI, previous abdominal surgery, and bilobar tumors are not a barrier for MILS. Laparoscopic and robotic liver resections for CRLM provide similar long-term results which are comparable to open techniques.

Sign in / Sign up

Export Citation Format

Share Document